Mild cognitive impairment diagnosed with the new DSM-5 criteria: Prevalence and associations with non-cognitive psychopathology

Acta Psychiatrica Scandinavica

Volumn 131, Issue 1, 2015, Pages 29-39

  Lopez Anton, R ^a,b   Santabarbara J ^a,b   De la Camara C ^a,b,c   Gracia Garcia P ^c   Lobo, E ^a,b   Marcos, G ^a,b   Pirez, G ^c   Saz, P ^a,b   Haro, J M ^a,d   Rodriguez Manas L ^e   Modrego, P J ^f   Dewey, M E ^g   Lobo, A ^a,b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d PARC SANITARI SANT JOAN DE DÉU   (Spain)

^e HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Community study; DSM 5; Mild cognitive impairment; Non cognitive psychopathological symptoms; Prevalence

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DSM-5; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PREVALENCE; PRIORITY JOURNAL; VERY ELDERLY; AGE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; LONGITUDINAL STUDY; MENTAL DISORDERS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SPAIN; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SPAIN;

EID: 84921020269     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12297     Document Type: Article

References (45)

1. Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C. Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol 2010;6:318-326.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
3. Sachdev PS, Brodaty H, Reppermund S et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010;22:1248-1264.
4. Gaser C, Franke K, Klöppel S et al. BrainAGE in mild cognitive impaired patients: predicting the conversion to Alzheimer's disease. PLoS One 2013;8:e67346.
5. Nickl-Jockschat T, Kleiman A, Schulz JB et al. Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: a meta-analysis. Brain Struct Funct 2012;217:115-125.
6. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252-265.
7. Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413-420.
8. Ganguli M, Chang CC, Snitz BE, Saxton JA, Vanderbilt J, Lee CW. Prevalence of mild cognitive impairment by multiple classifications: the Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project. Am J Geriatr Psychiatry 2010;18:674-683.
9. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005;162:667-675.
10. Gao S, Unverzagt FW, Hall KS et al. Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans. Am J Geriatr Psychiatry 2013;22:670-681.
11. Brodaty H, Heffernan M, Kochan NA et al. Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study. Alzheimers Dement 2013;9:310-317.
12. Shahnawaz Z, Reppermund S, Brodaty H et al. Prevalence and characteristics of depression in mild cognitive impairment: the Sydney Memory and Ageing Study. Acta Psychiatr Scand 2013;127:394-402.
13. Modrego PJ, Ferrández J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290-1293.
14. Richard E, Reitz C, Honig LH et al. Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol 2013;70:374-382.
15. Panza F, Capurso C, D'introno A et al. Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry 2008;23:726-734.
16. Vicini Chilovi B, Conti M, Zanetti M, Mazzù I, Rozzini L, Padovani A. Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2009;27:390-398.
17. Peters ME, Rosenberg PB, Steinberg M et al. Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. Am J Geriatr Psychiatry 2012;20:416-424.
18. Palmer K, di Iulio F, Varsi AE et al. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J Alzheimers Dis 2010;20:175-183.
19. Saz P, López-Antón R, Dewey ME et al. Prevalence and implications of psychopathological non-cognitive symptoms in dementia. Acta Psychiatr Scand 2009;119:107-116.
20. Lobo A, López-Antón R, De-la-Cámara C et al. Non-cognitive psychopathological symptoms associated with incident mild cognitive impairment and dementia. Alzheimer's type. Neurotox Res 2008;14:263-272.
21. Lobo A, Lopez-Anton R, Santabárbara J et al. Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population. Acta Psychiatr Scand 2011;124:372-383.
22. Copeland JR, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 1986;16:89-99.
23. Copeland JR, Dewey ME, Wood N, Searle R, Davidson IA, McWilliam C. Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry 1987;150:815-823.
24. Lobo A, Saz P, Marcos G, Día JL, De-la-Cámara C. The prevalence of dementia and depression in the elderly community in a southern European population. The Zaragoza study. Arch Gen Psychiatry 1995;52:497-506.
25. Dewey ME, Copeland JR. Diagnosis of dementia from the history and aetiology schedule. Int J Geriatr Psychiatry 2001;16:912-917.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
27. Lobo A, Saz P, Marcos G et al. Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin (Barc) 1999;112:767-774.
28. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
29. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
30. Gracia-García P, De-La-cámara C, Santabárbara J et al. Depression and incident Alzheimer disease: the impact of disease severity. Am J Geriatr Psychiatry 2013; doi: 10.1016/j.jagp.2013.02.015. [Epub ahead of print].
31. Katz MJ, Lipton RB, Hall CB et al. Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord 2012;26:335-343.
32. Ravaglia G, Forti P, Montesi F et al. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J Am Geriatr Soc 2008;56:51-58.
33. Fratiglioni L, Launer LJ, Andersen K et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S10-S15.
34. Petersen RC, Roberts RO, Knopman DS et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010;75:889-897.
35. Lipnicki DM, Sachdev PS, Crawford J et al. Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study. PLoS One 2013;8:e65841.
36. Alexopoulos GS, Borson S, Cuthbert BN et al. Assessment of late life depression. Biol Psychiatry 2002;52:164-174.
37. Gabryelewicz T, Styczynska M, Pfeffer A et al. Prevalence of major and minor depression in elderly persons with mild cognitive impairment-MADRS factor analysis. Int J Geriatr Psychiatry 2004;19:1168-1172.
38. Hidaka S, Ikejima C, Kodama C et al. Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depression. Int J Geriatr Psychiatry 2012;27:271-279.
39. Lee GJ, Lu PH, Hua X et al. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry 2012;71:814-821.
40. Palmer K, Berger AK, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007;68:1596-1602.
41. Richard E, Schmand B, Eikelenboom P et al. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord 2012;33:204-209.
42. Peters ME, Rosenberg PB, Steinberg M et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am J Geriatr Psychiatry 2013;21:1116-1124.
43. Luck T, Riedel-Heller SG, Luppa M et al. A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study. Acta Psychiatr Scand 2014;129:63-72.
44. Hughes TF, Snitz BE, Ganguli M. Should mild cognitive impairment be subtyped? Curr Opin Psychiatry 2011;24:237-242.
45. Lobo A, Quintanilla MA. The search of new biomarkers to identify Alzheimer's disease: an editorial comment to T Vanmierlo et al. 'The plant sterol brassicasterol and additional CFS biomarker in Alzheimer's Disease' (1). Acta Psychiatr Scand 2011;124:163-164.